Forte Biosciences

$1.24 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Forte Biosciences

Forte Biosciences, Inc., formerly Tocagen Inc., is a clinical-stage biopharmaceutical company. The Company is focused on clinical program and developing a live biotherapeutic for the treatment of inflammatory skin diseases, particularly for pediatric atopic dermatitis patients. It provides FB-401, which is a live biotherapeutic for the treatment of inflammatory skin diseases. FB-401 has completed Phase I/II a testing in adult and pediatric patients with atopic dermatitis.

Stock Analysis

last close $1.19
1-mo return -22.2%
3-mo return -3.3%
avg daily vol. 383.51T
52-week high 31.47
52-week low 1.03
market cap. $18M
forward pe -
annual div. -
roe -41.1%
ltg forecast -
dividend yield -
annual rev. $--
inst own. 53.1%
baraka

Subscribe now for daily local and international financial news

Subscribe